Announcements & Events
 Institute for OneWorld Health Awarded $46 Million Grant to Combat Diarrheal Disease
The Institute for OneWorld Health (iOWH) announced that it has been awarded a grant of $46 million from the Bill & Melinda Gates Foundation to continue and expand its unique research on new treatments to complement traditional approaches in fighting diarrhea. The announcement came at Forum 10, the Global Forum for Health Research’s annual meeting underway in Cairo, Egypt. Diarrheal diseases are a leading cause of death in children under the age of five worldwide, killing more than 2 million children and contributing to the deaths of 4 million children each year. Diarrheal diseases are caused by a wide range of bacterial, parasitic, and viral pathogens, some of which result in rapid fluid loss, and can lead to severe dehydration and death.
 Institute for OneWorld Health to Host Symposia at the 55th Annual ASTMH Meeting at the Atlanta Marquis Marriott in Atlanta, Georgia Nov 12-16, 2006
On Wednesday, Nov 15, 2006 the Institute for OneWorld Health will be hosting a symposium titled Getting In-Zinc: A discussion of zinc supplementation to combat diarrheal and other infectious diseases moderated by Susan Wilson, PhD of the Institute for OneWorld Health. Later that day we will be hosting a second symposium titled Three complementary approaches to meet the challenges of the artemisinin supply chain moderated by Thomas Brewer, MD, FACP of the Bill and Melinda Gates Foundation.
OneWorld Health in the News
The Institute for One World Health has been featured extensively in the news recently in publications ranging from Forbes magazine to Philanthropy Roundtable magazine. Visit our website to read these and other articles including “Bets on Biotech” published in US News & World Report in September.
Donate
 The Institute for OneWorld Health depends on the generous support of individuals all over the world to fulfill our mission. Thank you for supporting our work and helping us to develop and provide access to safe, effective, and affordable medicines for people with neglected diseases in the developing world.
|
